SPECC1L-ALK: A novel gene fusion response to ALK inhibitors in non-small cell lung cancer

被引：8
|
作者：
Ma, Li [1 ]
Zhang, Quan [1 ]
Dong, Yujie [2 ]
Li, Haoyang [1 ]
Wang, Jinghui [1 ]
机构：
[1] Capital Med Univ, Dept Med Oncol, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, 97 Ma Chang, Beijing 101149, Peoples R China
[2] Capital Med Univ, Dept Pathol, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing 101149, Peoples R China
来源：
LUNG CANCER | 2020年 / 143卷
关键词：
ADENOCARCINOMA; PATIENT;
D O I：
10.1016/j.lungcan.2020.03.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：97 / 100
页数：4
相关论文
共 50 条
  • [1] Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer
    Centonza, Antonella
    Mazza, Tommaso
    Trombetta, Domenico
    Sparaneo, Angelo
    Petrizzelli, Francesco
    Castellana, Stefano
    Centra, Flavia
    Fabrizio, Federico Pio
    Di Micco, Concetta Martina
    Benso, Federica
    Tabbo, Fabrizio
    Righi, Luisella
    Merlini, Alessandra
    Graziano, Paolo
    Muscarella, Lucia Anna
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [2] Efficacy and safety of iruplinalkib (WX-0593) on non-small cell lung cancer with SPECC1L-ALK fusion: A case report
    Zhang, Quan
    Lv, Jialin
    Li, Xi
    Zhang, Hui
    Zhu, Chenlin
    Wang, Meng
    Si, Meimei
    Hu, Ying
    Zhang, Shucai
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (02)
  • [3] Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer
    Shirish M. Gadgeel
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [4] Sequencing of ALK Inhibitors in ALK plus Non-Small Cell Lung Cancer
    Gadgeel, Shirish M.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (06)
  • [5] Tackling ALK in non-small cell lung cancer: the role of novel inhibitors
    Facchinetti, Francesco
    Tiseo, Marcello
    Di Maio, Massimo
    Graziano, Paolo
    Bria, Emilio
    Rossi, Giulio
    Novello, Silvia
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (03) : 301 - 321
  • [6] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer Response
    Park, Jae Yong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (05) : 578 - 578
  • [7] PLEKHM2-ALK: A novel fusion in small-cell lung cancer and durable response to ALK inhibitors
    Li, Tao
    Zhang, Fan
    Wu, Zhaozhen
    Cui, Longgang
    Zhao, Xiaochen
    Wang, Jinliang
    Hu, Yi
    [J]. LUNG CANCER, 2020, 139 : 146 - 150
  • [8] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    [J]. ONCOLOGY LETTERS, 2022, 24 (02)
  • [9] Trends in ALK inhibitors for non-small cell lung cancer.
    Meade, Denise
    Ng, Marie
    Alford, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] ALK inhibitors and advanced non-small cell lung cancer (Review)
    Rossi, Antonio
    Maione, Paolo
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Ferrara, Marianna Luciana
    Palazzolo, Giovanni
    Ciardiello, Fortunato
    Gridelli, Cesare
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 499 - 508
12345